Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 56,004 shares at $60.06 ($3.4M) on 2021-06-10, disclosed to the SEC on 2021-06-11.
Open-market sale of $3.4M AGIO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.16 | 7,149 | $430K | 12.8% |
| 2 | $60.16 | 7,149 | $430K | 12.8% |
| 3 | $60.06 | 20,853 | $1.3M | 37.2% |
| 4 | $60.06 | 20,853 | $1.3M | 37.2% |
| Total | $60.09 avg | 56,004 | $3.4M | 100% |
| Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |
| AGIO | SELL | 2020-05-21 | $358K | — | Filing → |